
Tag: Pulmonary Arterial Hypertension (PAH) Market
-

Date:
Pulmonary Arterial Hypertension (PAH) Market to Reach USD 13.5 Billion by 2028 — By Drug Class / Pipeline Analysis | U.S. • Germany • China • India
The global pulmonary arterial hypertension (PAH) market is witnessing steady growth, driven by increasing disease prevalence and advancements in drug development. The…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.



